bioAffinity Technologies gets Hong Kong patent for CyPath lung diagnostic
bioAffinity Technologies said Hong Kong’s Intellectual Property Department granted a patent covering its proprietary CyPath® noninvasive lung cancer diagnostic.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.